These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20581058)

  • 1. Loss of estrogen receptor 1 enhances cervical cancer invasion.
    Zhai Y; Bommer GT; Feng Y; Wiese AB; Fearon ER; Cho KR
    Am J Pathol; 2010 Aug; 177(2):884-95. PubMed ID: 20581058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.
    Zhai Y; Kuick R; Nan B; Ota I; Weiss SJ; Trimble CL; Fearon ER; Cho KR
    Cancer Res; 2007 Nov; 67(21):10163-72. PubMed ID: 17974957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
    Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
    Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
    Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
    Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
    Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
    Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of adrenomedullin expression in the invasion of squamous cell carcinoma of the uterine cervix.
    Li Z; Takeuchi S; Otani T; Maruo T
    Int J Clin Oncol; 2001 Dec; 6(6):263-70. PubMed ID: 11828944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the oncostatin M receptor in cervical squamous cell carcinoma cells is associated with a pro-angiogenic phenotype and increased cell motility and invasiveness.
    Winder DM; Chattopadhyay A; Muralidhar B; Bauer J; English WR; Zhang X; Karagavriilidou K; Roberts I; Pett MR; Murphy G; Coleman N
    J Pathol; 2011 Nov; 225(3):448-62. PubMed ID: 21952923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Alexander C; White M; Maleki Z; Rodriguez EF
    Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of calmodulin-like protein 5 as tumor-suppressor gene silenced during early stage of carcinogenesis in squamous cell carcinoma of uterine cervix.
    Kitazawa S; Takaoka Y; Ueda Y; Kitazawa R
    Int J Cancer; 2021 Sep; 149(6):1358-1368. PubMed ID: 33997976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic identification of key genes and pathways in the development of invasive cervical cancer.
    Niu G; Wang D; Pei Y; Sun L
    Gene; 2017 Jun; 618():28-41. PubMed ID: 28341182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix.
    Nakagawa S; Yoshikawa H; Kimura M; Kawana K; Matsumoto K; Onda T; Kino N; Yamada M; Yasugi T; Taketani Y
    Br J Cancer; 1999 Feb; 79(3-4):589-94. PubMed ID: 10027335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association of ESR1 methylation at promoter region with progression of cervical lesion in Uyghur women].
    Aliyeguli A; Abida A; He H; Abulizi A
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):765-6. PubMed ID: 23302339
    [No Abstract]   [Full Text] [Related]  

  • 13. ESR1 promoter methylation in squamous cell cervical cancer.
    Kirn V; Zaharieva I; Heublein S; Thangarajah F; Friese K; Mayr D; Jeschke U
    Anticancer Res; 2014 Feb; 34(2):723-7. PubMed ID: 24511005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis.
    Wang F; Liu X; Yang P; Guo L; Liu C; Li H; Long S; Shen Y; Wan H
    Cell Death Dis; 2014 Mar; 5(3):e1133. PubMed ID: 24651436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer.
    Fang J; Zhang M; Li Q
    Am J Med Sci; 2011 Sep; 342(3):198-204. PubMed ID: 21629038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
    Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
    Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.
    Muralidhar B; Goldstein LD; Ng G; Winder DM; Palmer RD; Gooding EL; Barbosa-Morais NL; Mukherjee G; Thorne NP; Roberts I; Pett MR; Coleman N
    J Pathol; 2007 Aug; 212(4):368-77. PubMed ID: 17471471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of insulin-like growth factor binding protein-5 (IGFBP-5): novel marker for cervical carcinogenesis.
    Miyatake T; Ueda Y; Nakashima R; Yoshino K; Kimura T; Murata T; Nomura T; Fujita M; Buzard GS; Enomoto T
    Int J Cancer; 2007 May; 120(10):2068-77. PubMed ID: 17290407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.